Loading research…
Fujian Haixi Pharmaceuticals Co., Ltd. Class H (HKEX: 2637)
Fujian Haixi Pharmaceuticals Co., Ltd. Class H trades on HKEX under the symbol 2637, quoted in HKD. The listing is associated with China. Its sector is Health technology, within Biotechnology. Reported figures retain their financial periods. Market prices and charts are shown separately from dated research.
- Exchange
- HKEX
- Country
- China
- Sector
- Health technology
- Industry
- Biotechnology
- Trading currency
- HKD
- ISIN
- CNE100007515
Reported financials
Research date October 28, 2026. Figures below are dated observations, not market quotes.
| Metric | Value | Period | Period end |
|---|---|---|---|
| Revenue | 81,132,877.42 USD | Annual | Dec 31, 2025 |
| Net income | 24,663,303.60 USD | Annual | Dec 31, 2025 |
| Diluted EPS | 0.35 USD | Annual | Dec 31, 2025 |
| Total assets | 264,226,868.73 USD | Annual | Dec 31, 2025 |
| Total debt | 15,759,751.28 USD | Annual | Dec 31, 2025 |
| Gross margin | 83.38% | Annual | Dec 31, 2025 |
| Operating margin | 33.02% | Annual | Dec 31, 2025 |
| Return on equity | 16.33% | Annual | Dec 31, 2025 |
| Return on assets | 13.42% | Annual | Dec 31, 2025 |
| Dividend per share | 0.00 USD | Annual | Dec 31, 2025 |
Stock ScreenerEarnings CalendarDividends CalendarStock investing guide
Data notes
Scores, valuation models and research metrics use dated FOLITIC research. Dates and currencies remain attached to their observations. Missing values are shown as a dash.
Market quotes and charts use the separate market-data display. Saved research prices and model comparisons are not live quotes. Model ranges represent sensitivity scenarios, not confidence intervals or price guarantees.
Listings on different exchanges and different share classes are kept separate. No currency conversion is applied to saved research values.